user

Glycopyrrolate/Formoterol Fumarate Fixed-Dose Combination Delivered by Metered Dose Inhaler Improves Lung Function and Symptoms in Patients with COPD: Results from the PINNACLE-4 Study in Asia, Europe, and the USA

被引：0
|
作者：
Lipworth, B. [1 ]
Collier, D. J. [2 ]
Gon, Y. [3 ]
Zhong, N. [4 ]
Nishi, K. [5 ]
Chen, R. [4 ]
Arora, S. [6 ]
Maes, A. [7 ]
Siddiqui, S. [8 ]
Reisner, C. [7 ]
Martin, U. J. [8 ]
机构：
[1] Univ Dundee, Ninewells Hosp, Scottish Ctr Resp Res, Dundee, Scotland
[2] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England
[3] Nihon Univ, Itabashi Hosp, Sch Med, Itabashi Ku, Tokyo, Japan
[4] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[5] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan
[6] Aventiv Res Inc, Columbus, OH USA
[7] Pearl Therapeut Inc, Morristown, NJ USA
[8] AstraZeneca, Gaithersburg, MD USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4236
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Singh, D.
    McLaren, J.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS
    Martinez, Fernando J.
    Ferguson, Gary T.
    Bourne, Eric
    Ballal, Shaila
    Darken, Patrick
    Aurivillius, Magnus
    Dorinsky, Paul
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 179 - 189
  • [23] A multicenter, randomized, double-blind dose ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropiurn dry powder inhaler in patients with moderate-to-severe COPD (vol 120, pg 16, 2016)
    Tashkin, Donald P.
    Martinez, Fernando J.
    Rodriguez-Roisin, Roberto
    Fogarty, Charles
    Gotfried, Mark
    Denenberg, Michael
    Gottschlich, Gregory
    Donohue, James F.
    Orevillo, Chad
    Darken, Patrick
    St Rose, Earl
    Strom, Shannon
    Fischer, Tracy
    Golden, Michael
    Reisner, Colin
    RESPIRATORY MEDICINE, 2017, 129 : 164 - 164
  • [24] Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Reducing Exacerbation Risk in Patients with Moderate-to-Very Severe COPD: A Pooled Analysis of the PINNACLE Studies
    Sethi, S.
    Lipworth, B. J.
    Ferguson, G. T.
    Arora, S.
    Jenkins, M.
    Maes, A.
    Martin, U. J.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] Evaluation of Potential for Pharmacokinetic Interaction Between Mometasone Furoate and Formoterol Fumarate After Oral Inhalation From a Fixed-Dose Combination Metered-Dose Inhaler Device
    Kosoglou, Teddy
    Hubbell, James
    Johnson-Levonas, Amy O.
    Yunan, Mona
    Kantesaria, Bhavna S.
    Cutler, David L.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (03): : 222 - 228
  • [26] Safety And Efficacy Of A Novel Lama/laba Co-Suspension Technology Glycopyrrolate/formoterol Fixed-Dose Combination Delivered By Mdi: Results Of A One-Year Extension Study In Patients With COPD (pinnacle-3)
    Hanania, N. A.
    Tashkin, D. P.
    Kerwin, E.
    Donohue, J.
    Denenberg, M.
    O'Donnell, D.
    Quinn, D.
    Siddiqui, S.
    Orevillo, C.
    Maes, A.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [27] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial
    Martinez, F. J.
    Rabe, K. F.
    Ferguson, G. T.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Efficacy and tolerability of aclidinium bromide/formoterol fumarate fixed-dose combination in patients with COPD: A 1-year study
    Make, Barry
    Donohue, James
    Soong, Weily
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [29] Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [30] A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
    De Backer, Wilfried
    De Backer, Jan
    Vos, Wim
    Verlinden, Ilse
    Van Holsbeke, Cedric
    Clukers, Johan
    Hajian, Bita
    Siddiqui, Shahid
    Jenkins, Martin
    Reisner, Colin
    Martin, Ubaldo J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2673 - 2684
12345